Form 483

Norwich Pharmaceuticals, Inc. Form 483, 2021-03-16

FDA issued a Form 483 to Norwich Pharmaceuticals, Inc. on 2021-03-16 with 6 public-safe observations.

483· Form 483 issuedHuman Drugs6 observations

Norwich Pharmaceuticals, Inc. · Norwich, United States · Issued March 16, 2021

Overview

  • 6 public-safe observations are available for this inspection.
  • 2 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

16 Mar 2021
21 CFR 211.63

Equipment Design, Size and Location

Cited by Mindy M Chou

16 Mar 2021
21 CFR 211.63

Equipment Design, Size and Location

Cited by Mindy M Chou

16 Mar 2021
21 CFR 211.63

Equipment Design, Size and Location

Cited by Mindy M Chou

16 Mar 2021
21 CFR 211.67(b)(3)

Cleaning SOPs/instructions

Cited by Mindy M Chou

16 Mar 2021
21 CFR 211.67(b)(3)

Cleaning SOPs/instructions

Cited by Mindy M Chou

Inspected site

NPNorwich Pharmaceuticals, Inc.Norwich, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.63Cited across public-safe Form 483 observations3x
21 CFR 211.67(b)(3)Cited across public-safe Form 483 observations3x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 6 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere